<DOC>
	<DOCNO>NCT02923505</DOCNO>
	<brief_summary>The aim study test hypothesis treatment sleep disorder breathing ( SDB ) patient comorbid chronic obstructive pulmonary disease ( COPD ) and/or heart failure ( HF ) positive airway pressure ( PAP ) associate reduce risk hospitalization death , low health care utilization , great cost-effectiveness .</brief_summary>
	<brief_title>Effect Positive Airway Pressure Therapy Hospitalization Mortality SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease ( COPD ) or/and Heart Failure ( HF )</brief_title>
	<detailed_description>In retrospective analysis health care utilization patient COPD HF quantify . Data patient additionally underwent polysomnography polygraphy 2012 2015 take consideration . The data ( risk hospitalization death , comorbidities , diagnosis therapy SDB , cost health care utilization ) collect 12 month 12 month diagnosis SDB . The patient ' medical record also review compliance treatment SDB , patient classify treat untreated . The treated group divide two subgroup : `` good adherence '' PAP therapy ( â‰¥ 4 hour PAP use per night ) `` poor adherence '' PAP therapy ( &lt; 4 hour PAP use per night ) . Healthcare Utilizations , HF COPD exacerbation mortality identify review medical record , National database available , self-reported patient patient 's family phone interview questionnaire .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>subject 21 75 year ; consecutive patient underwent polysomnography polygraphy period 01/01/2012 31/12/2015 . diagnosis COPD and/or HF age &lt; 21 &gt; 75 year</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>